There are many unanswered questions regarding the risk of cardiovascular disease (CVD), including myocardial infarction (MI), in human immunodeficiency virus (HIV)–infected individuals. Studies have suggested that rates of MIs may be higher in HIV-infected individuals vs those without HIV.
1-4 Human immunodeficiency virus may affect lipid levels and endothelial function, leading to increased risk of CVD.
5-7 Antiretroviral therapy (ART) has reduced HIV-associated morbidity and mortality,
8-11 but some ART agents, particularly older ones, may increase the risk of CVD.
12-15 Previous studies have used unadjudicated MI outcomes and have not differentiated the types of MI.
1,16,17 These limitations may have contributed to conflicting findings regarding CVD risk in HIV-infected populations.